Martin Plöderl (@ploederlm) 's Twitter Profile
Martin Plöderl

@ploederlm

Clinical psychologist & psychotherapist, cyclist, small-scale chicken keeper and scientist.
Bin privat hier.

ID: 1026912308533100547

linkhttps://martin-ploederl.jimdosite.com/ calendar_today07-08-2018 19:25:48

16,16K Tweet

3,3K Followers

685 Following

Eiko Fried (@eikofried) 's Twitter Profile Photo

1/ Blog concludes with "I’m fairly positive about ketamine and mental health". I was really surprised by this given the evidence the blog itself cites, in addition to some crucial evidence out there the blog misses. So let me go through a few points quickly. 🧵

André Herrmann (@antrehherrmann) 's Twitter Profile Photo

Ich sag nur: 2019. money quote: "Wenn Sie 2025 kein E-Mobil für unter 20.000 Euro anbieten, dann werden Sie - so fürchte ich - im Markt scheitern."

Ich sag nur: 2019.

money quote: "Wenn Sie 2025 kein E-Mobil für unter 20.000 Euro anbieten, dann werden Sie - so fürchte ich - im Markt scheitern."
Kasper Planeta Kepp (@kasperkepp) 's Twitter Profile Photo

Thank you for a great collaboration by a multidisciplinary expert team. Regardless of whether one endorses the views or not, organized zerocovid advocacy was extraordinary by its methods and views and warrants scientific scrutiny as a central part of pandemic history. #COVID

Martin Plöderl (@ploederlm) 's Twitter Profile Photo

Results for repeated doses, after 4 weeks tx / follow up, from a review with COIs thelancet.com/journals/eclin… I am fairly positive that there's a lot of uncertainty about the harm/benefit ratio of longer-term use of (es)ketamine. Big money is in endless treatment, of course.

Results for repeated doses, after 4 weeks tx / follow up, from a review with COIs
thelancet.com/journals/eclin…
I am fairly positive that there's a lot of uncertainty about the harm/benefit ratio of longer-term use of (es)ketamine.
Big money is in endless treatment, of course.
Prof. Michael S Fuhrer (@michaelsfuhrer) 's Twitter Profile Photo

Putrino Lab Read it: "It’s wrong to try to change minds by distorting the science." Please stop distorting science to scare people. This harms the prospects of finding treatments or a cure for long covid and post-viral syndromes. It doesn't take an epidemiologist to see you're lying. 1/

Martin Plöderl (@ploederlm) 's Twitter Profile Photo

Ok, most of the MDD sample were on antidepressants. Then there's some relevant COI. But most strikingly, as pointed out by several already, antidepressant treatment was not discussed as confounding variable at all.

Ok, most of the MDD sample were on antidepressants. 
Then there's some relevant COI. 
But most strikingly, as pointed out by several already, antidepressant treatment was not discussed as confounding variable at all.
Jacek Debiec MD, PhD, DPhil 🌎 (@debiecjacek) 's Twitter Profile Photo

I've seen many kids taking several psychiatric meds at a time. The most common reason for prescribing clinicians to be hesitant to prevent polypharmacy was a lack of knowledge and fear that the patient may "get worse." Safe deprescribing is a part of knowledge about prescribing.

Joar Øveraas Halvorsen (@joarhalvorsen) 's Twitter Profile Photo

This is from one of the foremost textbooks of psychotherapy. Isn't this quite questionable? To estimate the effect of psychotherapy for depression vs. pill-placebo, the authors averaged SMDs *only* for psychotherapies with *statistically significant SMDs* vs. pill-placebo?

This is from one of the foremost textbooks of psychotherapy. Isn't this quite questionable? To estimate the effect of psychotherapy for depression vs. pill-placebo, the authors averaged SMDs *only* for psychotherapies with *statistically significant SMDs* vs. pill-placebo?
Dr Joanna Moncrieff (@joannamoncrieff) 's Twitter Profile Photo

A very interesting essay: 'I think we’re at the beginning of a renaissance of alternative approaches... The ultimate goal of these movements is to create safe, non-coercive, therapeutic communities that give people space to explore alternative, meaning-making frameworks'

Sarah P. Hancock, MS, CRC ♿ (@psychrecovery) 's Twitter Profile Photo

"Between stimulus & response there is a space. In that space is our power to choose our response. In our response lies our growth & our freedom." -Victor Frankl I learned this & chose a diff path than my Drs who believed they knew me & my life's trajectory. #AskThePatient #ECT

"Between stimulus & response there is a space. In that space is our power to choose our response. In our response lies our growth & our freedom." 
-Victor Frankl

I learned this & chose a diff path than my Drs who believed they knew me & my life's trajectory. #AskThePatient #ECT
Florian Naudet (@naudetflorian) 's Twitter Profile Photo

🧵 on our recent The BMJ paper. Despite years of advocacy, data sharing in clinical trials isn’t the norm. But recent US policies could change this trend. #DataSharing #ClinicalTrials bmj.com/content/386/bm…

James Moore (@jf_moore) 's Twitter Profile Photo

Today’s the day! Join Mad In America for this online discussion with @samizdathealth of RxISK Why Are #Antidepressants So Difficult to Stop? A New Understanding of #Drug Dysregulation Syndrome and How to Manage It 10am PDT/1pm EDT/6pm BST Register: bit.ly/3XeV0uc

Andrew Althouse (@adalthousephd) 's Twitter Profile Photo

Matthew Yglesias alexa blue Tons of people get this wrong, by the way. It’s common even in the biomedical literature to see people describe the change in the placebo group before treatment vs after treatment as “the placebo effect” - but it’s wrong.

Martin Plöderl (@ploederlm) 's Twitter Profile Photo

Die Mediale Berichterstattung gehört vermutlich zum "Erfolg" des Terrorismus dazu. Beim Thema Suizid gibt es gute Ansätze, Nachahmung zu vermeiden. Wie ist das beim Thema Terrorismus? ocd.lcwu.edu.pk/cfiles/Interna…